Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
2 Top Passive Income Stocks to Buy Now
05:45am, Friday, 26'th Sep 2025
Building passive income is one of the most reliable ways to secure financial freedom. Instead of relying on active work for every paycheck, investors can put their money to work in dividend-paying sto
3 Absurdly Cheap Stocks You Can Buy for Less than $100 Right Now
03:50am, Friday, 26'th Sep 2025
Want to invest in some low-priced stocks that possess a lot of upside in the long run? The stocks listed below could be great options for bargain hunters, as each one trades at less than $100 per shar
Hearing Against Pfizer Set For 29 September In Contraceptive ‘Depo-Provera' Multidistrict Litigation Overseen By Levin Papantonio
03:37pm, Thursday, 25'th Sep 2025
PENSACOLA, Fla.--(BUSINESS WIRE)--A hearing in the Depo-Provera legal action against Pfizer Inc. (NYSE:PFE) will take place on Monday, 29 September at 9:00am CT in the United States Courthouse in Pens
Pfizer: Invest For The Yield, Not The Weight-Loss Drug Chase
03:22pm, Thursday, 25'th Sep 2025
Pfizer Inc. is acquiring Metsera for up to $7.2 billion, aiming to enter the weight-loss drug market despite late-stage entry and no ongoing Phase 3 trials. PFE's acquisition targets GLP-1-based obesi
Does This Acquisition Make Pfizer Stock a Great Buy?
09:30am, Thursday, 25'th Sep 2025
Remember Pfizer (PFE -0.46%), the giant pharmaceutical company that developed a COVID-19 vaccine within weeks of the pandemic hitting U.S. shores and got it approved within a year? It was the fastest
Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025
06:45am, Thursday, 25'th Sep 2025
NEW YORK--(BUSINESS WIRE)--ESMO Curtain Raiser.
3 Top Dividend Stocks to Buy and Hold Forever
05:00am, Thursday, 25'th Sep 2025
Dividends have quietly driven the bulk of stock market returns for over a century. While share prices grab headlines, reinvested dividends account for the majority of total returns in global equity ma
Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering.
04:12am, Thursday, 25'th Sep 2025
Weight loss drugs have represented an enormous growth area for biotech and pharma companies over the past couple of years. Pharma giants Eli Lilly and Novo Nordisk dominate the market with their drugs
The Smartest Dividend Stock to Buy With $1,000 Right Now
07:45am, Wednesday, 24'th Sep 2025
The winds of political change have hit the healthcare industry, with drug makers seemingly taking the brunt of the gale. Industry-leading companies like Pfizer (PFE 0.33%), Merck (MRK -0.63%), and Bri
Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?
06:35am, Wednesday, 24'th Sep 2025
Pfizer (PFE 0.33%) is highly likely to survive the current headwinds it faces in the pharmaceutical sector. It has a long history and a strong core business.
Where Will Pfizer Be in 5 Years?
03:55am, Wednesday, 24'th Sep 2025
A few years ago, Pfizer (PFE 0.33%) saw revenue soar to record heights thanks to coronavirus-related sales, from its vaccine Comirnaty and its treatment Paxlovid. On top of this, the company's blockbu
Time to Buy Pfizer (PFE) or Metsera (MTSR) Stock?
07:56pm, Tuesday, 23'rd Sep 2025
Making a major move in the obesity drug market, Pfizer (PFE) announced on Monday that it plans to acquire biotechnology firm Metsera (MTSR).
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale
Can PFE Successfully Return to the Obesity Space With Metsera Buyout?
01:21pm, Tuesday, 23'rd Sep 2025
Pfizer strikes a $4.9B deal for Metsera, adding obesity drug candidates to its pipeline after scrapping danuglipron.
Pfizer's Metsera buy raises competitive heat for Novo Nordisk
10:47am, Tuesday, 23'rd Sep 2025
UBS has warned that Pfizer Inc's (NYSE:PFE, ETR:PFE) $7.3 billion acquisition of Metsera will sharpen competition for Novo Nordisk (NYSE:NVO) in the fast-growing obesity drug market, particularly tow
